Perhaps, SS-OCTA of tumor-related vasculature will provide important clues about classifying tumor-related vasculature as active or quiescent in CO, and the vascular complexity of these tumor-related vasculature may provide factors of tumor growth and prognostic indications of whether they will respond to anti-VEGF therapy or recur after treatment. The gene discussed is VEGFA; the disease is neoplasm.